Avantis Medical Systems Enters Enormous Endoscope Market
Avantis Medical Systems is company that is tapping into large Endoscope market which has 30 million colonoscopies globally and 15 million in the US alone.
news2
International Stem Cell Corporation Progressing in Human Induced Stem Cells
International Stem Cell Corporation (OTCQB: ISCO) is a biotechnology company that focuses on developing novel stem cell based therapies. Most recently, they have made significant progress in human induced pluripotent stem cells (iPS) and its derivation with novel protein-based reprogramming method.
Plandai Biotechnology Sets for Battle Against Neurological Diseases by using Nutraceuticals
Plandaí Biotechnology, Inc. (OTCQB: PLPL) transforming the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market. These extracts are utilized to deliver a new family of drugs to safely and cost effectively treats a plethora of different diseases and conditions.
First-Mover Healthcare CrowdFunding Portals and Online Investment Firms to Present at 7th Annual OneMedForum San Francisco
OneMedForum announced today that it has assembled two panels featuring early entrants in the emerging areas of crowdfunding and online investment banking in healthcare. Panelists […]
OneMedRadio: Alliance Health Fund Revolutionizing Communication
A healthcare technology start-up is helping hospitals ensure that clinicians are present at the right time, in the right location, in a more efficient, cost-effective way. IntelliBlast, developed by healthcare technology start-up Targeted Instant Communications (TIC), is the first patented, bi-directional communications software that simplifies staff communications and the shift fulfillment process.
Monteris Medical Develops a Novel Treatment for Glioblastoma
Monteris Medical is a neurosurgical company with a focus on creating unique and innovative technology to treat serious brain disorders. Their flagship product, the Neuroblate Thermal Therapy System creates minimally invasive treatments for soft tissue and brain lesions
Diagnovus Focused on Delivering Personalized Diagnostic Information and Services to Physicians Treating Patients Suffering from Rare Diseases
Diagnovus is a specialized molecular diagnostic company, focused on delivering personalized diagnostic information and services to physicians treating patients suffering from rare, orphan and less frequent diseases. We are privileged for the opportunity to serve patients and the physicians treating them.
Regenesis Biomedical- Utilizing Energy to Reduce Pain
Regenesis Biomedical’s Provant Therapy System is FDA approved for the palliative treatment of post-operative pain and edema in superficial soft tissue. Post surgery, many tissues may be moved around or inflamed, but Provant helps reduce the pain by inducing endogenous opioids. This prescription only device exposes tissue to electromagnetic energy using an optimized energy pulse.
NeoStem Discovering the Power of Stem Cell Technology in Wound Care
Preliminary data in preclinical models of severe complex wounds suggests that human VSELs™ (very small embryonic like stem cells) accelerates wound healing. NeoStem hopes to advance into early clinical studies to assess therapeutic potential of VSEL technology.
NanoViricides’ drug FluCide found safe in small animal studies
Early results for the new flu drug FluCide® found to be safe in a non-GLP small animal safety/ toxicology study. These preliminary results support the company’s earlier reports of the FluCide® drug being effective in animal models of different influenza A virus strains. NanoViricides is also developing drugs against HIV/AIDS (HivCide™-I), Dengue (DengueCide™-I), and External Eye Viral disease (EKC-Cide™-I), amongst other viral diseases.